Please login to the form below

Not currently logged in
Email:
Password:

Takeda files US patent case

Takeda sues Dr Reddy's over patent infringements related to Dexilant drug

Takeda Pharmaceutical has filed a patent infringement suit against India's Dr Reddy's Laboratories in a New York court. The suit relates to efforts from Dr Reddy's to manufacture a generic version of Takeda's acid reflux treatment drug Dexilant (dexlansoprazole).

Takeda alleges that the Indian generic-drug maker and its US subsidiary have infringed US patent numbers through the submission of an abbreviated new drug application seeking approval to market generic versions of Dexilent.

The drug has an annual market size of more than $300m in the US market, according to IMS Health figures.

Dr Reddy's was unavailable for comment at the time of writing.

13th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics